---
title: "Liver and Steroid Hormones—Can a Touch of p53 Make a Difference?"
description: "Liver and Steroid Hormones—Can a Touch of p53 Make a Difference?"
url: liver_steroids
date: 2020/07/07
toc: true
excerpt: "Liver and Steroid Hormones—Can a Touch of p53 Make a Difference?"
tags: [Papers]
category: [Notes, Paper, Biology]
cover: 'https://s1.ax1x.com/2020/05/21/Yqgjuq.png'
thumbnail: 'https://s1.ax1x.com/2020/05/21/Yqgjuq.png'
priority: 10000
---

## Liver and Steroid Hormones—Can a Touch of p53 Make a Difference?

Cite: Charni-Natan M, Aloni-Grinstein R, Osher E and Rotter V (2019) Liver and Steroid Hormones—Can a Touch of p53 Make a Difference? Front. Endocrinol. 10:374. doi: 10.3389/fendo.2019.00374

[Read the full paper](https://www.frontiersin.org/articles/10.3389/fendo.2019.00374/full)
## General Information

### Background
***Liver***:
![Yqgjuq.png](https://s1.ax1x.com/2020/05/21/Yqgjuq.png)
© Charni 2019


## Abstract
1. Liver serving as a hormonal secretory gland.
2. Steroid hormones is important
3. Liver is important to Steroid hormones homeostasis
4. P53 has impact on Liver
5. Hypothesis: P53-> Liver -> Steroid hormones -> Diseases
6. New way to diseases treatment (Maybe)

## Introduction

### P1: BG
Steroid hormones:
- reproductive
- metabolic homeostasis

Steroid hormones synthesis
- derived from cholesterol
- synthesized by adrenal cortex, gonads, and placenta.

Five groups: (**based on nuclear receptor**)<sup id="b_p1">[(1–5)](#p1)</sup>
1. mineralocoriticoids
2. glucocorticoids
3. androgens
4. estrogens
5. progestogens

P53
- Responding for stress
- Regulating hormones expression

This discuss is focus on bidirectional relationship between different steroid hormones and liver and dependently on p53.


### Steroid Hormones Homeostasis Regulation by the Liver

#### Cholesterol
Cholesterol Genesis<sup id="b_p2">[(15)](#p2)</sup>
- de-novo production
- hydrolysis of stored cholesterol
- interiorization of plasma membrane cholesterol
- from LDL and HDL

####  Metabolism
Metabolism<sup id="b_p3">[(16, 17)](#p3)</sup>
- 5αR1 (liver enzyme 5α-reductase 1)
  - 5αR1-KO mice exhibited augmented mRNA levels of various hepatic metabolic regulators genes (e.g., Acc1, Agpat2, Cpt2, and Dgat2) in comparison to WT mice<sup id="b_p4">[(18)](#p4)</sup>.
- CYP (cytochromes P450 enzymes)
  - metabolism of many drugs and lipophilic compounds<sup id="b_p5">[(19)](#p5)</sup>
  - CYP3A4, CYP19, CYP2C2B1, and CYP2C11 are the liver CYPs and take part in steroid hormones hydroxylation and processing
  - CYP3A4<sup id="b_p6">[(20,21)](#p6)</sup>
    - hydroxylases several steroids such as cortisol, androstenedione, testosterone, and progesterone
  - CYP19 (Aromatase)<sup id="b_p7">[(10)](#p7)</sup>
    - transforms androgens to estrogens by the removal of C19 carbon and the aromatization of the steroid A ring.
  - CYP2C11 and CYP2B1<sup>[(10)](#p7)</sup>
    - regulate hydroxylation of testosterone
  - Nuclear receptors complexes
    - NRC such as PXR, VDR, RXR were also found to bind CYP3A4 chromatin and affect its expression <sup id="b_p8">[(23, 24)](#p8)</sup>

#### Steroids Conjunction
  - exerted by such as sulfotransferare and uridine diphosphate-glucuronosyltransferases (UGT)
    - ransfer the steroid hormones into higher polarity metabolites that are better suited to be excreted from the body<sup>[(10)](#p7)</sup>.
    - The sulfotransferases that are expressed by hepatic cells and are related to steroids conjugations are HSST, EST, SULT 2A1, and SULT 1E1 <sup id="b_p9">[(25)](#p9)</sup>.
    - be regulated by androgens, GCs, and nuclear receptors such as PXR<sup id="b_p11">[(27)](#p11)</sup>.
  - sulfotransferase inhibition
    - as well as EST KO, led to the acceleration of free steroids and thus to sexual abnormalities <sup id="b_p10">[(10](#p7),[26)](#p10)</sup>.

#### UGTs
- Two subfamilies
  - UGT2B
    - mainly expressed in the liver and is related the processing of steroid hormones<sup id="b_p12">[(28)](#p12)</sup>.
- UGT
  - it induce **glucuronidation** of steroids, a process that **interrupts steroids activity**, and enables their **elimination**.
  - Tegulated by several xenobiotics compounds (e.g., PCN, PB), which were reported to increase their mRNA expression levels in rats’ livers <sup id="b_p13">[(29)](#p13)</sup>.

#### Transportation
As steroids, these hormones are lipophilic thus, when secreted into the blood stream they need to be bound to carrier proteins
- SHBG (Sex hormone binding globulin)
- CBG (Corticosteroid binding globulin)
- This carriers are glycoproteins which are mainly secreted by liver.<sup id="b_p14">[(30, 31)](#p14)</sup>.
- Carrier proteins bind steroids and turn them to be biologically inactive <sup id="b_p15">[(32)](#p15)</sup>.
- effect different molecular pathways and signaling such as apoptosis <sup id="b_p16">[(33, 34)](#p16)</sup>
- Regulation:
  -  factors such as glucose <sup id="b_p17">[(35)](#p17)</sup>, thyroid hormone < id="b_p18"sup>[(36)](#p18)</sup>, and other factors such as the hepatocyte nuclear factor 4α (HNF-4α) <sup id="b_p19">[(37)](#p19)</sup>, PPAR-γ <sup id="b_p20">[(38)](#p20)</sup>, and p53 <sup id="b_p21">[(14)](#p21)</sup>.

### Glucocorticoids (GC)

Glucocorticoids are vital ***endocrine regulators*** of homeostasis and adaptation to environmental variations.
**potent anti-inflammatory** and **immunosuppressive agents**<sup id="b_p22">[(40)](#p22)</sup>
- Cortisol<sup id="b_p23">[(42)](#p23)</sup>
  - a main glucocorticoid secreted by the adrenal cortex
  - essential for immune system, vascular tone maintance
  - etc
   Played a major role during stress and severe illness by increasing cardiac output and vascular tonus and decreasing pro-inflammatory cytokines release<sup id="b_p24">[(43,44)](#p24)</sup>
  - under the control of: <sup id="b_p23">[(42)](#p23)</sup>
    - HPA (hypothalamus-pituitary-adrenal )
    - ACTH (adrenocorticotropic hormone)
    - CRH (corticotropin-releasing hormone)
    - low-density lipoproteins (LDL) cholesterol insufficiency impair the production of cortisol <sup id="b_p25">[(45)](#p25)</sup>


### NAFLD (Non-alcoholic fatty liver disease)
Metabolic disorder, characterized by hepatic steatosis, the presence of free fatty acids or triglycerides in the liver<sup>(46)</sup>.  
- Mice:
  - high fat diets & chronically elevated GC<sup>(47)</sup>
- Patients:
  - elevated GC levels<sup>(48)</sup>

(**Skip**)

### Mineralocorticoids
synthesized by the **adrenal cortex** that influence **salt and water** balance.

(**Skip**)

### Androgens
Androgens are the principal male sex hormones that regulated masculinizing (雄性化作用) effects and male sexual behavior.
- DHT(dehydroepiandrosterone)
  - it can bind androgen receptor(AR) as well as ***testosterone***(82)

### Estrogens
Estrogens are female principal sex hormone.
- E2 (17β estradiol) is essential for human

...


---
## Citation


1. [1. ](#b_p1)Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M. Multiple actions of steroid hormones–a focus on rapid, non-genomic effects. Pharmacol Rev. (2000) 52:513–56.  
2. [2. ](#b_p1)Becker KL. Principles and Practice of Endocrinology and Metabolism. Lippincott Williams & Wilkins (2001).
3. [3. ](#b_p1)Holst JP, Soldin OP, Guo T, Soldin SJ. Steroid hormones: relevance and measurement in the clinical laboratory. Clin Lab Med. (2004) 24:105–18. doi: 10.1016/j.cll.2004.01.004
4. [4. ](#b_p1)Frye CA. Steroids, reproductive endocrine function, and affect. A review. Minerva Ginecol. (2009) 61:541–62.
5. [5. ](#b_p1)Birzniece V. Hepatic actions of androgens in the regulation of metabolism. Curr Opin Endocrinol Diabetes Obes.(2018) 25:201–8. doi: 10.1097/MED.0000000000000405<p id="p2"></p>

6. [15. ](#b_p2)Hu J, Zhang Z, Shen WJ, Azhar S. Cellular cholesterol delivery, intracellular
processing and utilization for biosynthesis of steroid hormones. Nutr Metab.
(2010) 7:47. doi: 10.1186/1743-7075-7-47<p id="p3"></p>

7. [16. ](#b_p3)Thigpen AE, Silver RI, Guileyardo JM, Casey ML, Mcconnell JD, Russell DW. Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression. J Clin Invest. (1993) 92:903–10. doi: 10.1172/JCI116665

8. [17. ](#b_p3)El-Awady MK, El-Garf W, El-Houssieny L. Steroid 5α reductase mRNA type 1 is differentially regulated by androgens and glucocorticoids in the rat liver. Endocr J. (2004) 51:37–46. doi: 10.1507/endocrj.51.37<p id="p4"></p>

9. [18. ](#b_p4)Livingstone DE, Di Rollo EM, Mak TC, Sooy K, Walker BR, Andrew R. Metabolic dysfunction in female mice with disruption of 5α-reductase 1. J Endocrinol. (2017) 232:29–36. doi: 10.1530/JOE-16-0125<p id="p5"></p>

10. [19. ](#b_p5)Zimniak P, Waxman DJ. Liver cytochrome P450 metabolism of endogenous steroid hormones, bile acids, and fatty acids. In: Schenkman JB, Greim H, editors. Cytochrome P450. Berlin, Heidelberg: Springer Berlin Heidelberg (1993) p. 123–44. doi: 10.1007/978-3-642-77763-9_8<p id="p6"></p>

11. [20. ](#b_p6)Waxman DJ, Attisano C, Guengerich FP, Lapenson DP. Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6 β-hydroxylase cytochrome P-450 enzyme. Arch Biochem Biophys. (1988) 263:424–36. doi: 10.1016/0003-9861(88)90655-8
12. [21. ](#b_p6)Niwa T, Murayama N, Imagawa Y, Yamazaki H. Regioselective hydroxylation of steroid hormones by human cytochromes P450. Drug Metab Rev. (2015) 47:89–110. doi: 10.3109/03602532.2015.1011658<p id="p7"></p>

13. [10. ](#b_p7)You L. Steroid hormone biotransformation and xenobiotic induction of hepatic steroid metabolizing enzymes. Chem Biol Interact. (2004) 147:233–46. doi: 10.1016/j.cbi.2004.01.006<p id="p8"></p>

14. [23. ](#b_p8)Wang K, Chen S, Xie W, Wan YJ. Retinoids induce cytochrome P450 3A4 through RXR/VDR-mediated pathway. Biochem Pharmacol. (2008) 75:2204–13. doi: 10.1016/j.bcp.2008.02.030
15. [24. ](#b_p8)Istrate MA, Nussler AK, Eichelbaum M, Burk O. Regulation of CYP3A4 by pregnane X receptor: The role of nuclear receptors competing for response element binding. Biochem Biophys Res Commun. (2010) 393:688–93. doi: 10.1016/j.bbrc.2010.02.058<p id="p9"></p>

16. [25. ](#b_p9)Strott CA. Sulfonation and molecular action. Endocr Rev. (2002) 23:703–32. doi: 10.1210/er.2001-0040<p id="p10"></p>

1. [26. ](#b_p10)Strott CA. Sulfonation and molecular action. Endocr Rev. (2002) 23:703–32. doi: 10.1210/er.2001-0040<p id="p11"></p>

1. [27. ](#b_p11)Runge-Morris M, Wu W, Kocarek TA. Regulation of rat hepatic hydroxysteroid sulfotransferase (SULT2-40/41) gene expression by glucocorticoids: evidence for a dual mechanism of transcription<p id="p12"></p>

1. [28. ](#b_p12)Girard C, Barbier O, Veilleux G, El-Alfy M, Belanger A. Human uridine diphosphate-glucuronosyltransferase UGT2B7 conjugates mineralocorticoid and glucocorticoid metabolites. Endocrinology. (2003) 144:2659–68. doi: 10.1210/en.2002-0052<p id="p13"></p>

1. [29. ](#b_p13)Vansell NR, Klaassen CD. Increase in rat liver UDP glucuronosyltransferase mRNA by microsomal enzyme inducers that enhance thyroid hormone glucuronidation. Drug Metab Dispos. (2002) 30:240–6. doi: 10.1124/dmd.30.3.240<p id="p14"></p>

1. [30. ](#b_p14)Avvakumov GV, Cherkasov A, Muller YA, Hammond GL. Structural analyses of sex hormone-binding globulin reveal novel ligands and function. Mol Cell Endocrinol. (2010) 316:13–23. doi: 10.1016/j.mce.2009.09.005
1. [31. ](#b_p14)Lin HY, Muller YA, Hammond GL. Molecular and structural basis of steroid hormone binding and release from corticosteroid-binding globulin. Mol Cell Endocrinol. (2010) 316:3–12. doi: 10.1016/j.mce.2009.06.015<p id="p15"></p>

1. [32. ](#b_p15) Mendel CM. The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev. (1989) 10:232–74. doi: 10.1210/edrv-10-3-232<p id="p16"></p>

1. [33. ](#b_p16)Fortunati N, Catalano MG, Boccuzzi G, Frairia R. Sex hormone-binding globulin (SHBG), estradiol and breast cancer. Mol Cell Endocrinol. (2010) 316:86–92. doi: 10.1016/j.mce.2009.09.012
1. [34. ](#b_p16)Hammond GL. Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action. J Endocrinol. (2016) 230:R13–25. doi: 10.1530/JOE-16-0070<p id="p17"></p>

1. [35. ](#b_p17)De Moor P, Joossens JV. An inverse relation between body weight and the activity of the steroid binding -globulin in human plasma. Steroidologia. (1970) 1:129–36.<p id="p18"></p>

1. [36. ](#b_p18)Javitt NB. Hep G2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids. FASEB J. (1990) 4:161–8. doi: 10.1096/fasebj.4.2.2153592<p id="p19"></p>

1. [37. ](#b_p19)Selva DM, Hogeveen KN, Innis SM, Hammond GL. Monosaccharideinduced lipogenesis regulates the human hepatic sex hormone-binding globulin gene. J Clin Invest. (2007) 117:3979–87. doi: 10.1172/JCI32249<p id="p20"></p>

1. [38. ](#b_p20)Selva DM, Hammond GL. Peroxisome-proliferator receptor γ represses hepatic sex hormone-binding globulin expression. Endocrinology. (2009) 150:2183–9. doi: 10.1210/en.2008-1289<p id="p21"></p>

1. [14. ](#b_p21)Charni M, Molchadsky A, Goldstein I, Solomon H, Tal P, Goldfinger N, et al. Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation. Cell Death Differ. (2016) 23:509–20. doi: 10.1038/cdd.2015.119<p id="p22"></p>

1. [40. ](#b_p22) Vandewalle J, Luypaert A, De Bosscher K, Libert C. Therapeutic Mechanisms of Glucocorticoids. Trends Endocrinol Metab. (2018) 29:42–54. doi: 10.1016/j.tem.2017.10.010<p id="p23"></p>

1. [42. ](#b_p23)Arlt W, Stewart PM. Adrenal corticosteroid biosynthesis, metabolism, and action. Endocrinol Metab Clin North Am. (2005) 34:293–313. doi: 10.1016/j.ecl.2005.01.002<p id="p24"></p>

1. [43. ](#b_p24)Snijdewint FG, Kapsenberg ML, Wauben-Penris PJ, Bos JD. Corticosteroids class-dependently inhibit in vitro Th1- and Th2- type cytokine production. Immunopharmacology. (1995) 29:93–101. doi: 10.1016/0162-3109(94)00048-K

1. [44. ](#b_p24)Yang S, Zhang L. Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol. (2004) 2:1–12. doi: 10.2174/1570161043476483<p id="p25"></p>

1. [45. ](#b_p25)Cicognani C, Malavolti M, Morselli-Labate AM, Zamboni L, Sama C, Barbara L. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med. (1997) 157:792–6. doi: 10.1001/archinte.1997.00440280120012<p id="p26"></p>


1. [45. ](#b_p25)Cicognani C, Malavolti M, Morselli-Labate AM, Zamboni L, Sama C, Barbara L. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med. (1997) 157:792–6. doi: 10.1001/archinte.1997.00440280120012<p id="p26"></p>

46. Tsochatzis EA, Newsome PN. Non-alcoholic fatty liver disease and the interface between primary and secondary care. Lancet Gastroenterol Hepatol. (2018) 3:509–17. doi: 10.1016/S2468-1253(18)30077-3

47. D’souza AM, Beaudry JL, Szigiato AA, Trumble SJ, Snook LA, Bonen A, et al. Consumption of a high-fat diet rapidly exacerbates the development of fatty liver disease that occurs with chronically elevated glucocorticoids. Am J Physiol Gastrointest Liver Physiol. (2012) 302:G850–63. doi: 10.1152/ajpgi.00378.2011

48. Rockall AG, Sohaib SA, Evans D, Kaltsas G, Isidori AM, Monson JP, et al. Hepatic steatosis in Cushing’s syndrome: a radiological assessment using computed tomography. Eur J Endocrinol. (2003) 149:543–8. doi: 10.1530/eje.0.1490543

82. Shen M, Shi H. Sex hormones and their receptors regulate liver energy homeostasis. Int J Endocrinol. (2015) 2015:294278. doi: 10.1155/2015/294278
